Literature DB >> 35505015

Subcutaneous Xenograft Models for Studying PDT In Vivo.

Girgis Obaid1, Tayyaba Hasan2.   

Abstract

The most facile, reproducible, and robust in vivo models for evaluating the anticancer efficacy of photodynamic therapy (PDT) are subcutaneous xenograft models of human tumors. The accessibility and practicality of light irradiation protocols for treating subcutaneous xenograft models also increase their value as relatively rapid tools to expedite the testing of novel photosensitizers, respective formulations, and treatment regimens for PDT. This chapter summarizes the methods used in the literature to prepare various types of subcutaneous xenograft models of human cancers and syngeneic models to explore the role of PDT in immuno-oncology. This chapter also summarizes the PDT treatment protocols tested on the subcutaneous models, and the procedures used to evaluate the efficacy at the molecular, macromolecular, and host organism levels.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cell lines; Immunocompetent models; Patient-derived xenografts; Photodynamic therapy; Syngeneic models

Mesh:

Substances:

Year:  2022        PMID: 35505015     DOI: 10.1007/978-1-0716-2099-1_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  41 in total

Review 1.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

2.  Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.

Authors:  Shifalika Tangutoori; Bryan Q Spring; Zhiming Mai; Akilan Palanisami; Lawrence B Mensah; Tayyaba Hasan
Journal:  Nanomedicine       Date:  2015-09-25       Impact factor: 5.307

3.  Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery.

Authors:  Huang-Chiao Huang; Imran Rizvi; Joyce Liu; Sriram Anbil; Ashish Kalra; Helen Lee; Yan Baglo; Nancy Paz; Douglas Hayden; Steve Pereira; Brian W Pogue; Jonathan Fitzgerald; Tayyaba Hasan
Journal:  Cancer Res       Date:  2017-11-29       Impact factor: 12.701

4.  Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates.

Authors:  Bryan Q Spring; Adnan O Abu-Yousif; Akilan Palanisami; Imran Rizvi; Xiang Zheng; Zhiming Mai; Sriram Anbil; R Bryan Sears; Lawrence B Mensah; Ruth Goldschmidt; S Sibel Erdem; Esther Oliva; Tayyaba Hasan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-26       Impact factor: 11.205

5.  Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI.

Authors:  Shimon Gross; Assaf Gilead; Avigdor Scherz; Michal Neeman; Yoram Salomon
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

6.  Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo.

Authors:  Qi Xie; Lin Jia; Yan-Hong Liu; Cheng-Gang Wei
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

7.  Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model.

Authors:  B A Goff; J Blake; M P Bamberg; T Hasan
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

8.  Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging.

Authors:  Srivalleesha Mallidi; Kohei Watanabe; Dmitriy Timerman; David Schoenfeld; Tayyaba Hasan
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556

9.  A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways.

Authors:  Bryan Q Spring; R Bryan Sears; Lei Zak Zheng; Zhiming Mai; Reika Watanabe; Margaret E Sherwood; David A Schoenfeld; Brian W Pogue; Stephen P Pereira; Elizabeth Villa; Tayyaba Hasan
Journal:  Nat Nanotechnol       Date:  2016-01-18       Impact factor: 39.213

10.  Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive.

Authors:  E A Lindsay; M C Berenbaum; R Bonnett; D G Thomas
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.